home / stock / myd / myd news


MYD News and Press, Blackrock MuniYield Fund Inc. From 01/21/25

Stock Information

Company Name: Blackrock MuniYield Fund Inc.
Stock Symbol: MYD
Market: NYSE
Website: www.blackrock.com

Menu

MYD MYD Quote MYD Short MYD News MYD Articles MYD Message Board
Get MYD Alerts

News, Short Squeeze, Breakout and More Instantly...

MYD - BlackRock Announces Board Approval of Closed-End Fund Reorganizations

BlackRock Advisors, LLC announced today that each of the Boards of Directors/Trustees of each of the closed-end funds named below (each, a “Fund” and collectively, the “Funds”) has approved the following reorganizations (each, a “Reorganization” and colle...

MYD - Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

SALT LAKE CITY, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced select unaudited preliminary results for the fourth quarter and full year ended December 31, 2024, and provided full year 2025 financial ...

MYD - Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement with Hannah Storm , a nationally renowned sports broadcaster, who recently revealed her battle with breast cancer. Under ...

MYD - UPDATE - Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

News release updated to include the members of the management team speaking at the conference. SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CE...

MYD - Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan...

MYD - MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad's molecular residual disease assay

HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc . today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular residual dis...

MYD - Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its Quality, Innovation, and Corporate Responsibility Report, highlighting key efforts that reflect its commitment to conduct operations ...

MYD - Trend Tracker for (MYD)

2025-01-06 03:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10